Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability Enhancement: Drug Permeability Enhancement
Drug Products: Biologics, Biosimilars and Interchangeables
Drug Control Governance: Regulatory Bodies and Their Impact
Prescription, Nonprescription and Orphan Drugs
Drug Regulation
こちらも読む
共著者、ジャーナル、引用グラフによってこの研究に関連する記事。
Robert M Califf1,2, Andrew Slavitt3
1Duke Forge, Duke University School of Medicine, Durham, North Carolina.
No abstract available in PubMed .